TREN E 200
Category: Injectable Steroids
Active ingredient: Trenbolone Enanthate
Packaging: 10 ml / 2000 mg
Manufacturer: Human Labs
Half-life: 4 to 5 days
Abused dose: most commonly 150 to 600 mg weekly
There are 54 products.
Active filters
Category: Injectable Steroids
Active ingredient: Trenbolone Enanthate
Packaging: 10 ml / 2000 mg
Manufacturer: Human Labs
Half-life: 4 to 5 days
Abused dose: most commonly 150 to 600 mg weekly
Category: Injectable Steroids
Active ingredient: Drostanolone Propionate
Packaging: 10 ml / 1000 mg
Manufacturer: Human Labs
Half-life: 1 to 2 days
Abused dose: most commonly 300 to 800 mg weekly
Category: Injectable Steroids
Active ingredient: Drostanolone Enanthate
Packaging: 10 ml / 2500 mg
Manufacturer: Human Labs
Half-life: 4 to 5 days
Abused dose: most commonly 300 to 800 mg weekly
Category: Injectable Steroids
Active ingredient: Methenolone Enanthate
Packaging: 10 ml / 1000 mg
Manufacturer: Human Labs
Half-life: 4 to 5 days
Abused dose: most commonly 400 to 800 mg weekly
Category: Injectable Steroids
Active ingredient: Testosterone Undecanoate
Packaging: 10 ml / 2500 mg
Manufacturer: General Pharmaceuticals
Half-life: 20 to 33 days
Abused dose: most commonly 200 to 1000 mg per week
Category: Injectable Steroids
Active Ingredient: Trenbolone Hexahydrobenzylcarbonate
Packaging: 10 ml / 765 mg
Manufacturer: General Pharmaceuticals
Half-Life: 8 to 10 days
Misused Dose: Most commonly 150 to 600 mg per week
Category: Injectable Steroids
Active Ingredient: Trestolone Acetate
Packaging: 10 ml / 1000 mg
Manufacturer: General Pharmaceuticals
Half-Life: Up to 24 hours
Misused Dose: Most commonly 25 to 100 mg daily
Category: Injectable Substances (Peptide Hormone)
Active Ingredient: Thymosin Beta 4
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 3.5 to 7 hours
Dosage: Taken at a dose of 2.5 to 6 mg per week, with the dose divided into 2 to 3 doses per week
Category: Injectable Substances (GLP-1 Receptor Agonist, weight-loss medication)
Active Ingredient: Semaglutide
Packaging: Vial containing 4 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 7 days
Dosage: Most commonly 0.5 to 1 mg weekly (from 0.25 to 1 mg weekly)
Category: Injectable compounds (GLP-1 and GIP receptor agonist, medication for weight loss support)
Active ingredient: Tirzepatide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5 days
Dosage: Most commonly 2.5 to 15 mg weekly (typically starting at 2.5 mg per week with gradual dose escalation based on tolerance)
Category: Injectable compounds (GLP-1, GIP, and glucagon receptor agonist; experimental weight loss medication)
Active ingredient: Retatrutide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5–7 days
Dosage: Most commonly 2.5 to 12 mg weekly (typically titrated gradually based on tolerance)
Category: Synthetic peptide (GHRP)
Active ingredient: Ipamorelin
Packaging: 2 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: approx. 2 hours
Abused dose: 100 to 300 mcg daily